Christopher j logothetis
WebDr. Christopher J. Logothetis has a longstanding interest in genitourinary cancers—germ cell tumors, bladder, renal, and most recently in his career, prostate cancer. His research experience preceded the development of effective chemotherapy and extends to the current era of molecular targeted therapies and classification of cancer. He was ... Web期刊：European Urology文献作者：Silke Gillessen; Alberto Bossi; Ian D. Davis; Johann de Bono; Karim Fizazi; Nicholas D. James; Nicolas Mottet; Neal Shore; E ... Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: …
Christopher j logothetis
Did you know?
WebAU - Logothetis, Christopher J. AU - Lin, Sue Hwa. PY - 2008/8/1. Y1 - 2008/8/1. N2 - Bone is the most common site of metastases from prostate cancer. The mechanism by which prostate cancer cells metastasize to bone is not fully understood, but interactions between prostate cancer cells and bone cells are thought to initiate the colonization of ... WebApr 11, 2024 · PURPOSE We have previously developed and externally validated a prognostic model of overall survival (OS) in men with metastatic, castration-resistant prostate cancer (mCRPC) treated with docetaxel. We sought to externally validate this model in a broader group of men with docetaxel-naïve mCRPC and in specific subgroups …
WebChristopher J. Logothetis Introduction The rational application of integrated multidisciplinary therapy of prostate cancer (PC) requires an understanding of the determinants of cancer progression and response to therapy to successfully treat common adult cancers. In the successful WebHe received his medical degree from University of Western Ontario and has been in practice for more than 20 years. Specialties Specialty Urology Urologists specialize in the male and female urinary...
WebDr. Christopher J. Logothetis is an oncologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He … Webabstract BACKGROUND: Innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer. However, we still lack high-level evidence in many areas relevant to making management decisions in daily clinical practise.
WebShare. Dr. Christopher J. Logothetis is internationally recognized for his research in prostate cancer, with new combinations of cytotoxic drugs and preoperative gene therapy. Dr. Christopher J. Logothetis is …
WebAs an oncologist, Dr. Logothetis is trained to diagnose and treat all types and forms of cancer. Dr. Logothetis may employ a variety of diagnostic tests such as biopsies, … goldair wall mount fan with remote white 40cmgold air ventsWebChristopher J. Logothetis, MD, has substantial experience both as an investigator in clinical and applied research and as a leader in multidisciplinary research programs. He … goldair washing machineWebBilal A Siddiqui 1 , Brian F Chapin 2 , Sonali Jindal 3 , Fei Duan 3 , Sreyashi Basu 3 , Shalini S Yadav 3 , Ai-Di Gu 3 , Alexsandra B Espejo 3 , Michelle Kinder 4 , Curtis A Pettaway 2 … goldair websiteWebHospitals Education & Experience Overview Dr. Ana M. Aparicio is an oncologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. She … goldair whisper quietWebChristopher J Logothetis 1 , Gary E Gallick, Sankar N Maity, Jeri Kim, Ana Aparicio, Eleni Efstathiou, Sue-Hwa Lin Affiliation 1 Departments of 1Genitourinary Medical Oncology, … gold airwaysWebMar 31, 2024 · Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013 Jul 1;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12 … goldair weighted heated blanket - 4.5kg